Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options

Epithelial ovarian cancer (EOC) is a significant cause of cancer-related mortality in women. Despite advances in diagnosis and treatment, EOC remains a challenging disease to manage, and the 5-year survival rate is still poor. The role of hormone receptors (HRs) in EOC carcinogenesis and prognosis h...

Full description

Bibliographic Details
Main Authors: Fulvio Borella, Stefano Fucina, Luca Mangherini, Stefano Cosma, Andrea Roberto Carosso, Jessica Cusato, Paola Cassoni, Luca Bertero, Dionyssios Katsaros, Chiara Benedetto
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
ovarian cancer
hormone therapy
endocrine therapy
hormone receptors
aromatase inhibitors
fulvestrant
Online Access:https://www.mdpi.com/2227-9059/11/8/2157

Internet

https://www.mdpi.com/2227-9059/11/8/2157

Similar Items